Series date: 
01/07/2021 - 4:00pm EST to 12/31/2024 - 5:00pm EST

Sessions

Session Datesort ascending
The ADAPT trial for myasthenia gravis 05/31/2023 - 3:30pm to 4:03pm EDT
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant 02/22/2023 - 3:30pm to 4:30pm EST
Drug dosing in patients undergoing therapeutic plasma exchange 01/25/2023 - 3:30pm to 4:30pm EST
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease 11/09/2022 - 3:30pm to 4:30pm EST
Safety and Tolerability of Solvent/Detergent-Treated Plasma for Pediatric Patients Requiring Therapeutic Plasma Exchange 10/19/2022 - 3:30pm to 4:30pm EDT
A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus Host Disease 08/31/2022 - 3:30pm to 4:30pm EDT
Safety of Therapeutic Apheresis in Children and Adolescents 08/10/2022 - 3:30pm to 4:30pm EDT
Low hematocrit reduces the efficiency of CD34+ cell collection when using the Spectra Optia CMNC procedure 06/22/2022 - 3:30pm to 4:30pm EDT
Related PBSC donors experience more severe symptoms and less complete recovery than unrelated donors 01/26/2022 - 4:00pm to 5:00pm EST
Use of plasma exchange for pediatric multi-inflammatory syndrome in children (MIS-C) 12/22/2021 - 4:00pm to 5:00pm EST

Pages